1 215

Cited 0 times in

대한부인종양ㆍ콜포스코피학회의 4가 인유두종 바이러스 백신 접종 권고안

DC FieldValueLanguage
dc.contributor.author김영태-
dc.contributor.author조남훈-
dc.date.accessioned2014-12-21T17:05:31Z-
dc.date.available2014-12-21T17:05:31Z-
dc.date.issued2007-
dc.identifier.issn1226-1742-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/96929-
dc.description.abstractGenital HPV infection is the most common sexually transmitted infection, but the majority of infections are self-limited. However, persistent infection with high-risk types can cause cervical cancer in women, which is the most common female genital cancer in Korea. In addition, HPV infection is the cause of genital warts and is associated with other anogenital cancers. The HPV vaccine is composed of the HPV L1 protein, the major capsid protein of HPV. Expression of the L1 protein in yeast using recombinant DNA technology produces noninfectious virus-like particles (VLP) that resemble HPV virions. The quadrivalent HPV vaccine is a mixture of four HPV type-specific VLPs prepared from the L1 proteins of HPV 6, 11, 16, and 18 combined with an aluminum adjuvant. Clinical trials indicate that the vaccine has high efficacy in preventing persistent HPV infection, cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions, and genital warts caused by HPV types 6, 11, 16, or 18 among females who have not already been infected with the respective HPV type. The recommended age for primary vaccination of Korean females is 15-17 years, considering sexual debut and duration of protection of the vaccine. Vaccine can be administered as young as age 9 years. Catch-up vaccination is recommended for females aged 18-26 years who have not been previously vaccinated. Vaccination is not a substitute for routine cervical cancer screening, and vaccinated females should have cervical cancer screening as recommended.-
dc.description.statementOfResponsibilityopen-
dc.format.extent259~283-
dc.relation.isPartOfKorean Journal of Gynecologic Oncology (부인종양)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title대한부인종양ㆍ콜포스코피학회의 4가 인유두종 바이러스 백신 접종 권고안-
dc.title.alternativeRecommendation guideline of Korean Society of Gynecologic Oncology and Colposcopy for quadrivalent human papillomavirus vaccine-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학)-
dc.contributor.googleauthor김병기-
dc.contributor.googleauthor이낙우-
dc.contributor.googleauthor이규완-
dc.contributor.googleauthor박종섭-
dc.contributor.googleauthor허수영-
dc.contributor.googleauthor조치흠-
dc.contributor.googleauthor조남훈-
dc.contributor.googleauthor이원철-
dc.contributor.googleauthor이재관-
dc.contributor.googleauthor송용상-
dc.contributor.googleauthor박상윤-
dc.contributor.googleauthor김찬주-
dc.contributor.googleauthor김용만-
dc.contributor.googleauthor김영태-
dc.contributor.googleauthor김승철-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00729-
dc.contributor.localIdA03812-
dc.relation.journalcodeJ02020-
dc.identifier.urlhttp://kiss.kstudy.com/journal/thesis_name.asp?tname=kiss2002&key=2650099-
dc.contributor.alternativeNameKim, Young Tae-
dc.contributor.alternativeNameCho, Nam Hoon-
dc.contributor.affiliatedAuthorKim, Young Tae-
dc.contributor.affiliatedAuthorCho, Nam Hoon-
dc.rights.accessRightsnot free-
dc.citation.volume18-
dc.citation.number4-
dc.citation.startPage259-
dc.citation.endPage283-
dc.identifier.bibliographicCitationKorean Journal of Gynecologic Oncology (부인종양), Vol.18(4) : 259-283, 2007-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.